A senior nurse’s 40-year career has been suspended after a tribunal found she systematically forged doctor prescriptions for controlled medication. Jenny Maree Selfe was disqualified from the medical ...
“Ozempic is about to be old news,” my colleague Yasmin Tayag wrote in 2023, just before an even more powerful obesity drug, tirzepatide, then best known as Mounjaro, was approved. Well, two years ...
November 20, 1995 marked Queen Elizabeth and Prince Philip's 48th wedding anniversary, but on the same night, the Royal Family was faced with one of its biggest scandals when Princess Diana's Panorama ...
Scripta’s unique approach is based on the concept that transcription factors, the master controllers of gene expression, are core drivers of disease and act as detailed and dynamic maps of the ...
$12 million seed funding round led by Oxford Science Enterprises and Apollo Health Ventures, with AlbionVC, YZR Capital, and Parkwalk Advisors, and support from Oxford University Innovation Scripta ...
In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory pathway that could trigger a seismic shift in how bespoke gene editing therapies ...
Alex Murdaugh's attorney reacts to the 'Murdaugh: Death in the Family,' Hulu show saying "whoever wrote the script needs to be 'drug tested.'" Tensions Erupt as Venezuela Deploys Troops Jane Seymour ...
Cigna's Evernorth division is rolling out a rebate-free model for its pharmacy benefit manager, Express Scripts—meaning one of the industry's "Big Three" is moving away from the oft-criticized ...
One of the largest pharmacy benefits managers in the U.S. is overhauling how millions of its commercial members pay for drugs, in a move that should save consumers money at the pharmacy counter while ...
Healthcare costs are nearing double-digit increases, but benefit managers can make smart adjustments to their plans to brace for the impact. Processing Content Employers are predicting a 9% increase ...
Researchers at Mass General Brigham in Boston have designed a custom gene editing technique that corrected the mutation behind a rare blood vessel disease in mice, paving the way for further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback